VOGX Fail-to-Deliver

Vogenx Inc. (VOGX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $239.2M, listed on NASDAQ, employing roughly 4 people, carrying a beta of 0.00 to the broader market. Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. Led by James Green, public since 2026-08-12.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Latest Date
2026-09-25
Latest FTD Quantity
36
Latest Price
$24.20
30-Day Avg FTD
11.3K
30-Day Total FTD
214.4K

Showing 19 days of SEC fail-to-deliver data for Vogenx Inc..

Learn how fails-to-deliver is reported and how to read the data →

Frequently asked VOGX fail to deliver questions

What is the latest VOGX fail-to-deliver count?
As of Sep 25, 2026, Vogenx Inc. (VOGX) fail-to-deliver quantity is 36 shares, with a 19-day average of 11.3K shares. The SEC publishes FTD data twice monthly: first-half data at month-end, second-half around the 15th of the following month.
What is the FTD aggregate net balance?
FTD figures represent the aggregate net balance in NSCC's Continuous Net Settlement (CNS) system, not the gross failed-share count. The published numbers run 2-6 weeks stale relative to the underlying settlement date.
How do VOGX FTDs affect options pricing?
Persistent FTDs flag hard-to-borrow conditions that distort put-call parity: in HTB names, synthetic long stock (long call + short put at the same strike) trades below the frictionless-parity price by approximately the borrow rebate. The discount equals the lending revenue forgone by holding the synthetic instead of actual shares. Reg SHO threshold-list inclusion follows from sustained FTD persistence.